US 10857203
Methods and compositions for treating Huntington's disease
granted A61KA61K38/1709A61P
Quick answer
US patent 10857203 (Methods and compositions for treating Huntington's disease) held by Sangamo Therapeutics, Inc. expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/1709, A61P, A61P25/14, A61P43/00